New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback